Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Global FKRP Registry is a study aimed at better understanding certain genetic conditions caused by mutations in the FKRP gene. These conditions include Limb Girdle Muscular Dystrophy type R9 (LGMDR9), which is the most common FKRP-related disorder, along with rarer conditions like Congenital Muscular Dystrophy, Muscle-Eye-Brain Disease, and Walker-Warburg Syndrome. By gathering information through questionnaires from patients around the world, the registry hopes to gain valuable insights into these diseases and identify individuals who may be eligible for future clinical trials.
If you or a family member have a confirmed diagnosis of any FKRP-related condition, you may be eligible to participate in this registry, regardless of your age or gender. There are no specific exclusions, so anyone with a genetic confirmation of these conditions can join. Participants can expect to fill out questionnaires that will help researchers learn more about their experiences with the disease. This is an important step in advancing research and potentially leading to new treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients with a confirmed diagnosis of an FKRP-related condition are eligible for inclusion. Diagnosis will be confirmed via genetic testing results.
- Exclusion Criteria:
- • There is no exclusion criteria for registration with this patient registry.
About Newcastle University
Newcastle University is a leading research institution located in the United Kingdom, renowned for its commitment to advancing healthcare through innovative clinical trials and scientific research. The university's Clinical Trials Unit plays a pivotal role in the design, coordination, and execution of high-quality clinical studies, focusing on a wide range of therapeutic areas. With a multidisciplinary team of experts, Newcastle University fosters collaboration between academia, industry, and healthcare providers, ensuring that research findings translate into meaningful advancements in patient care. Its dedication to excellence and ethical standards positions Newcastle University as a trusted sponsor in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newcastle Upon Tyne, , United Kingdom
Newcastle Upon Tyne, , United Kingdom
Patients applied
Trial Officials
Volker Straub, MD, PhD
Principal Investigator
John Walton Muscular Dystrophy Research Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials